Cargando…
Potential Prognostic and Predictive Role of Monocyte and Lymphocyte Counts on Presentation in Patients Diagnosed With Diffuse Large B-Cell Lymphoma
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin’s lymphoma. Nearly 40% of patients will die of relapsed disease despite the use of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy. Many prognostic markers es...
Autores principales: | Kharroubi, Darine M, Nsouli, Ghazi, Haroun, Zeinab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065310/ https://www.ncbi.nlm.nih.gov/pubmed/37009375 http://dx.doi.org/10.7759/cureus.35654 |
Ejemplares similares
-
Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era
por: Ho, Ching-Liang, et al.
Publicado: (2015) -
Extranodal Diffuse Large B-cell Lymphoma With Primary Clinical Presentation as Acute Cholecystitis: A Case Report
por: Rössler, Fabian, et al.
Publicado: (2023) -
Pancreatic Diffuse Large B-cell Lymphoma in the US Population
por: Ullah, Asad, et al.
Publicado: (2023) -
It's Not Always Gynecomastia: A Case of Diffuse Large B-Cell Lymphoma Presenting as Breast Mass in a Male Patient
por: Leon, Amie, et al.
Publicado: (2021) -
Inflammatory Myalgia, A Rare Presentation of Hodgkin's Lymphoma: About a Case
por: Chergaoui, Ilyass, et al.
Publicado: (2023)